TSO3 Inc (fka TSTIF)

[teq0904]

The analysts downplay the duo approval and use silly conservative estimates like late in 2018 for approval, when the reality is this next submission is just more of the same kind of data showing scopes are not damaged using TOS device - they sent this before and FDA already accepted but wants more examples.

https://app.box.com/s/yhi6n1ozxxqjpke53j40xiyyv5653ktq

About the only interesting report is Scotia with 2 user testimonials and TSO3 calculation that every sale is worth $1M over the lifetime of the device. 3,000 sterilizers wear out every year although that includes the OR size which TOS doesn’t have at present but will at some point. Or consider there are 30k sterilizers out there and will be more once TOS gets FDA approval for the duodenoscope because every US hospital will need one.
Echelon said the list of US hospitals sued over disinfected duodenoscopes that resulted in infections and deaths is long and growing. No matter how tiny TOS sales force is, if US hospitals want an insurance policy against $4M lawsuits that costs nothing (opex savings will cover the capital costs over time) then they will gladly install a VP4 and junk their disinfection washer systems – at that point, even unmotivated Getinge salesmen will be able to make this easy sale.